hyperbilirubinemia. Neonatal jaundice, unspecified
Conditions
Interventions
Intervention 1: Intervention group: full-term infants over 5.2 kg and more than 72 hours after birth, who do not have evidence of direct jaundice and sepsis, treated with UDCA capsules at a dose of 15
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Days to 30 Days
Inclusion criteria
Inclusion criteria: The criteria for inclusion in the study include full-term infants (37-41 weeks) postnatal age greater than or equal to 72 hours and weighing more than 2.5 kg billirubin T<18
Exclusion criteria
Exclusion criteria: direct hyperbillirubinemia symptoms of sepsis prematurity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accelerate the reduction of bilirubin. Timepoint: Measurement of total bilirubin level at 12, 24, 36 and 48 hours. Method of measurement: Total bilirubin serum level by diazo method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of hospitalization. Timepoint: During the study by measuring serum bilirubin. Method of measurement: measuring serum bilirubin.;Time of separation between mother and baby. Timepoint: During the study by measuring serum bilirubin. Method of measurement: measuring serum bilirubin.;Reducing treatment costs. Timepoint: During the study by measuring serum bilirubin. Method of measurement: measuring serum bilirubin.;Reducing parents' worries are secondary outcomes. Timepoint: During the study by measuring serum bilirubin. Method of measurement: measuring serum bilirubin. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Musa Ahmadpoor
Babol University of Medical Sciences
Outcome results
None listed